天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片
上海阿拉丁生化科技股份有限公司 Company Information
Company Name:
Shanghai Aladdin Biochemical Technology Co.,Ltd.
Tel:
400-6206333
Email:
market@aladdin-e.com
Nationality:
China
WebSite:
www.aladdin-e.com/
Product List:
48461
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
Product List
Telazorlimab (anti-TNFRSF4)
2126777-87-3
Dysprosium(III) trifluoromethanesulfonate
139177-62-1
Bis(hexamethylene)triamine
143-23-7
Dehydroepiandrosterone sulfate
651-48-9
Xentuzumab (anti-IGF1)
1417158-65-6
Bimagrumab (anti-ACVR2B)
1356922-05-8
Meropenem-d6
1133424-00-6
Imazapic
104098-48-8
IDO-IN-13
2291164-02-6
Ethyl 2-oxo-4-phenylbutyrate
64920-29-2
Ranibizumab (anti-VEGFA)
347396-82-1
Nadecnemab (anti-GFRA3)
2377679-19-9
Benzyldiphenylphosphine
7650-91-1
Codrituzumab (anti-GPC3)
1365267-33-9
Urelumab (anti-TNFRSF9)
934823-49-1
Elotuzumab (anti-SLAMF7)
915296-00-3
Quetmolimab (anti-CX3CL1)
2084037-83-0
Bexmarilimab (anti-STAB1)
2259301-27-2
Narsoplimab (anti-MASP2)
2108782-45-0
8-Azahypoxanthine
2683-90-1
Sirtratumab (anti-SLITRK6)
1824663-82-2
Rosmantuzumab (anti-RSPO3)
1684393-04-1
Bivatuzumab (anti-CD44v6)
214559-60-1
Apelin 17 TFA
217082-57-0
Tamrintamab (anti-DPEP3)
2148325-59-9
Cinpanemab (anti-Alpha-synuclein)
2094516-02-4
Mogamulizumab (anti-CCR4)
1159266-37-1
Alizarin Yellow R sodium salt
1718-34-9
2-(azetidin-1-yl)ethan-1-amine
795299-77-3
Tesnatilimab (anti-NKG2D)
2242758-08-1
Lacnotuzumab (anti-M-CSF)
1831128-32-5
Tesidolumab (anti-Complement C5)
1531594-08-7
Sonepcizumab (anti-Sphingosine-1-phosphate)
1031360-18-5
Galiximab (anti-CD80)
357613-77-5
Idactamab (anti-SLC1A5)
2245205-37-0
Apamistamab (anti-PTPRC)
2097132-02-8
Ravulizumab (anti-Complement C5)
1803171-55-2
Itolizumab (anti-CD6)
1116433-11-4
Lumiliximab (anti-FceR2)
357613-86-6
Vopratelimab (anti-ICOS)
2039148-04-2
KWAR23 (anti-SIRPg)
2243227-60-1
Narnatumab (anti-RON)
1188275-92-4
Tisotumab (anti-F3)
1418628-81-5
Zagotenemab (anti-Tau)
2019133-28-7
Vandortuzumab (anti-STEAP1)
1557989-52-2
Ladiratuzumab (anti-SLC39A6)
1629760-28-6
Concizumab (anti-TFPI)
1312299-39-0
Serplulimab (anti-PDCD1)
2231029-82-4
Lexatumumab (anti-TNFRSF10B)
845816-02-6
Vunakizumab (anti-IL-17a)
1792181-33-9
Indusatumab (anti-GUCY2C)
1497400-26-6
Ulocuplumab (anti-CXCR4)
1375830-34-4
Vantictumab (anti-FZD)
1345009-45-1
Fulranumab (anti-NGF)
902141-80-4
Ianalumab (anti-TNFRSF13C)
1929549-92-7
Gevokizumab (anti-IL-1b)
1129435-60-4
Pascolizumab (anti-IL-4)
331243-22-2
Gemtuzumab (anti-CD33)
220578-59-6
Seribantumab (anti-ERBB3)
1334296-12-6
Tarextumab (anti-NOTCH3)
1359940-55-8
Zansecimab (anti-ANGPT2)
2415205-37-5
Vorsetuzumab (anti-CD70)
1165740-62-4
Lemzoparlimab (anti-CD47)
2377483-71-9
Flanvotumab (anti-TYRP1)
1188277-05-5
Guselkumab (anti-IL-23)
1350289-85-8
Ixekizumab (anti-CTLA-8)
1143503-69-8
Oxelumab (anti-TNFSF4)
1186098-83-8
Sirukumab (anti-IL-6)
1194585-53-9
Ragifilimab (anti-TNFRSF18)
2207590-51-8
Depatuxizumab mafodotin (anti-EGFR)
1585973-65-4
Belimumab (anti-TNFSF13B)
356547-88-1
Dostarlimab (anti-PD-1)
2022215-59-2
Daclizumab (anti-IL2RA)
152923-56-3
Tinurilimab (anti-CEACAM6)
2226224-30-0
Otilimab (anti-GM-CSF)
1638332-55-4
Ocrelizumab (anti-CD20)
637334-45-3
Rilotumumab (anti-HGF)
872514-65-3
Emibetuzumab (anti-MET)
1365287-97-3
Enfortumab (anti-NECTIN4)
1448664-46-7
Prezalumab (anti-B7-H2)
1523164-68-2
Enoblituzumab (anti-CD276)
1353485-38-7
Avdoralimab (anti-C5AR1)
2226393-85-5
Labetuzumab govitecan (anti-CEACAM5)
1469876-18-3
Girentuximab (anti-CA9)
916138-87-9
Datopotamab (anti-TROP2)
2267989-53-5
Imaprelimab (anti-CD146)
2014343-04-3
Abelacimab(anti-Factor XI)
2098724-83-3
Dinutuximab (anti-GD2)
1363687-32-4
Efalizumab (anti-ITGAL)
214745-43-4
Carotuximab (anti-CD105)
1268714-50-6
Ontamalimab (anti-MADCAM1)
2098790-40-8
Brazikumab (anti-IL-23)
1610353-18-8
Enokizumab (anti-IL-9)
909875-08-7
Eldelumab (anti-CXCL10)
946414-98-8
Daxdilimab (anti-ILT7)
2245966-28-1
Bermekimab (anti-IL-1a)
1401965-15-8
Ponsegromab (anti-GDF15)
2368950-15-4
Denintuzumab (anti-CD19)
1630074-14-4
Inebilizumab (anti-CD19)
1299440-37-1
Eculizumab (anti-Complement C5)
219685-50-4
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
Copyright 2007© ChemicalBook. All rights reserved.